Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer riskAllison W Kurian, Meredith A Mills, Margo Jaffee, et al.Cancer|September 5, 2014
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panelNadine Tung, Chiara Battelli, Brian Allen, et al.Oncotarget|May 7, 2016
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinomaTakashi Eguchi, Kyuichi Kadota, Jamie Chaft, et al.Breast Cancer Research and Treatment|December 25, 2017
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancerMelinda L Telli, Jessica Hellyer, William Audeh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2014
Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinomaRaphael Bueno, Elisha Hughes, Susanne Wagner, et al.Journal of Cutaneous Pathology|March 3, 2015
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanomaLoren E Clarke, M B Warf, Darl D Flake, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Cancer Susceptibility Gene Mutations in Individuals With Colorectal CancerMatthew B Yurgelun, Matthew H Kulke, Charles S Fuchs, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 31, 2014
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE studyDavid B Zhen, Kari G Rabe, Steven Gallinger, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 6, 2017
Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical OutcomesJennifer S Ko, Balwir Matharoo-Ball, Steven D Billings, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast CancerSteven J Isakoff, Erica L Mayer, Lei He, et al.Pageof 4